A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

What was supposed to be a five-year, $750,000 NIH grant to fund Dr. Charity Oyedeji's sickle cell research at Duke University ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

Extreme pain, known as a pain crisis, is one of the hallmark symptoms of SCD. With frequent hospitalizations, chronic pain ...

Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.

Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding cut, justified by NIH as a move against diversity, equity, and inclusion ...

Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...

In a sharply divided political climate, San Rocco Therapeutics (SRT) has done what few thought possible—earned support from both the highest levels of Washington and from those who distrust it.

With gene therapy in the works, clinical trials for sickle cell disease still lack Black American participants.

Nicole and Kyle Law have a strong bond. “She’s always there for me whenever I need her. Being sick and being healthy, too.

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...